Pharmafile Logo
Pharmafocus logo
Advanced Search

lilly

Showing 15 posts of 211 posts found.

lilly_entrance_web

FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug

May 12, 2016
Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition

The US Food and Drug Administration (FDA) has issued a new warning to all drug labels for Eli Lilly’s antipsychotic …

News
jardiance-web

Lilly and Boehringer Ingelheim to evaluate diabetes drug for treatment of heart failure

April 20, 2016
Research and Development Boehringer Ingelheim, Eli Lilly, cardiovascular death, diabetes, heart attack, jardiance, lilly

Eli Lilly (NYSE: LLY) and Boehringer Ingelheim have announced plans to conduct two outcome trials evaluating diabetes medicine Jardiance (empagliflozin) …

News
pharma_pill_manufacturing

AstraZeneca and Eli Lilly to enter Phase III on Alzheimer’s clinical trials

April 8, 2016
Medical Communications AZD3293, Alzheimer's, Alzheimers, AstraZeneca, amaranth, clinical trial, lilly, phase III

AstraZeneca and Eli Lilly have announced the continuation of their clinical trial for people with early Alzheimer’s disease into Phase …

News
manufacturing

Sun to cut jobs in Irish facility closure; Lilly announce further investment in the country

April 6, 2016
Manufacturing and Production, Research and Development Eli Lilly, Ireland, Kinsale, Sun Pharma, cashel, investment, lilly

There was mixed news for pharmaceutical manufacturing in Ireland as Sun Pharma announced its decision to close its facility based …

News
Brain scan

Lilly and Roche team up on new Alzheimer’s diagnostic test

January 28, 2016
Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly

Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …

News
eli_lilly_logo

Lilly awaits FDA review of new arthritis treatment

January 20, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, FDA, Incyte, NDA, baricitinib, lilly, new drug application, rheumatoid arthritis

Eli Lilly has submitted a new drug application (NDA) to the FDA for baricitinib as a treatment for moderate-to-severe rheumatoid …

News
EU flag

Three AstraZeneca drugs recommended by EMA committee

December 21, 2015
Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …

News
FDA sign

FDA approves Lilly/Boehringer Lantus biosimilar

December 17, 2015
Medical Communications, Sales and Marketing Basaglar, Boehringer Ingelheim, Eli Lilly, Lantus, Sanofi, abasaglar, biosimilar, diabetes, insulin, lilly

The FDA has approved Eli Lilly and Boehringer Ingelheim’s long-acting insulin Basaglar (insulin glargine injection – a biosimilar to rival Sanofi’s …

News
Lilly_labs_2

Lilly pulls plug on basal insulin Peglispro

December 8, 2015
Manufacturing and Production R&D, basal insulin peglispro, diabetes, lilly, peglispro, phase III failure

Lilly has decided to pull out of filing its diabetes drug basal insulin peglispro, after failing to convince regulators and …

News
Chest x ray

Lilly cancer drug gets US approval

November 26, 2015
NSCLC, Portrazza, lilly, lung cancer, necitumumab, non-small cell lung cancer, oncology

Eli Lilly has received FDA approval for its monoclonal antibody Portrazza, in combination with gemcitabine and cisplatin, for patients with …

News

Lilly/Incyte RA drug bests Humira in Phase III trial

November 10, 2015
Research and Development Humira, baricitinib, lilly, phase III, rheumatoid arthritis

Eli Lilly says its investigational therapy baricitinib outperformed AbbVie’s Humira after 12 weeks in a late-stage study of people with …

News

Jardiance scores more cardiovascular outcomes data

November 10, 2015
Manufacturing and Production Boehringer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Victoza, cardiovascular outcomes, diabetes, empagliflozin, jardiance, lilly, liraglutide, type 2 diabetes

A sub-group analysis of data from an outcomes study of Boehringer Ingelheim’s and Lilly’s Jardiance has found the diabetes drug …

News
lilly_entrance_web

Lilly shares fall as company abandons evacetrapib development

October 13, 2015
Manufacturing and Production evacetrapib, high cholesterol, lilly, phase III, phase III failure

Eli Lilly shares fell by nearly 8% this week as the company announced it will abandon developmenty of the investigational …

News
Abasaglar

Lilly and Boehringer launch biosimilar insulin in the UK

August 26, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly

Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …

News

Lilly set for Cymbalta lawsuit showdown

August 5, 2015
Research and Development cymbalta, duloxetine, lawsuit, lilly

Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026